TD Cowen Maintains Starbucks (SBUX) Price Target, Downgrades Rating
Starbucks Corporation (NASDAQ:SBUX) was downgraded by TD Cowen on May 29 from Buy to Hold, with the firm maintaining its $90 price target.
Insider Monkey Blog
Citi Raises Macy’s (M) Price Target, Maintains Neutral Rating
Citi analyst Paul Lejuez raised his price target on Macy’s Inc. (NYSE:M) to $12 from $11 on May 29, citing improving sales trends and a stronger-than-expected first quarter.
Best THCA Flower: Explore Black Tie’s THCA Collection in 2025
At the forefront of the legal hemp-derived cannabis movement is Black Tie CBD, a brand recognized for producing dispensary-quality THCA flower that's lab-tested, legally shipped...
BofA Lifts Pure Storage (PSTG) Target Price After Q1 FY26 Results
Wamsi Mohan of BofA Securities revised his rating outlook on Pure Storage, Inc.
H.C. Wainwright Backs Olema Pharmaceuticals (OLMA) as Phase 3 Trials Advance
H.C. Wainwright reiterated its Buy rating and $28 price target for Olema Pharmaceuticals, Inc.
H.C. Wainwright Reiterates Buy on Halozyme (HALO), Maintains Price Target
H.C. Wainwright's Mitchell Kapoor maintained Halozyme Therapeutics Inc. (NASDAQ:HALO) at a $72 price target and a Buy rating on May 29.
RBC Reaffirms Outperform on Regeneron (REGN) Ahead of Key COPD Drug Results
Analyst Brian Abrahams reiterated an Outperform rating and a price target of $943 for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on May 29.
Performance Food Group Company (PFGC) Stock Rated Outperform by BMO Following Growth-Focused Analyst Day
Analysts at BMO Capital outlined the key observations from Performance Food Group's May 28 Analyst Day.
CrowdStrike Price Target Raised by UBS Amid Bullish Growth Outlook
With revenue expanding at a rate of 29.39% and earnings due in less than a week, Boyd does not see recent developments—like staff layoffs and the Carahsoft/IRS deal—to be ...
Capri Holdings (CPRI) Stock Target Cut by BofA After EPS Miss
BofA Securities lowered its price target for Capri Holdings Limited (NYSE:CPRI) from $23 to $21 on May 29 while maintaining its Neutral rating for the company's shares.
Taysha Gene Therapies (TSHA) Price Target Raised by JMP on Positive Rett Syndrome Trial Data
On May 29, JMP Securities Silvan Tuerkcan revised the firm's view on Taysha Gene Therapies, Inc.
Bernstein Maintains Outperform Rating on United Parcel Service (UPS) After CEO’s Strategy Talk
Bernstein analysts reiterated their Outperform rating and $133 price target for United Parcel Service, Inc.
Rhythm Pharmaceuticals (RYTM) Gets Price Target Upgrade by Stifel Amid Obesity Drug Optimism
On May 29, analysts at Stifel raised their price target for Rhythm Pharmaceuticals Inc.
Jim Cramer Prefers GE Vernova Over NuScale Power Corporation (SMR)
We recently published a list of 8 Stocks on Jim Cramer’s Radar.
Jim Cramer on Leidos Holdings, Inc. (LDOS): “I Think It’s a Good Opportunity”
We recently published a list of 8 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Leidos Holdings, Inc.
Jim Cramer Thinks Lululemon Athletica Inc. (LULU) “Can Continue Making a Comeback”
We recently published a list of 8 Stocks on Jim Cramer’s Radar.
Jim Cramer on Interactive Brokers Group, Inc. (IBKR): “I Say Buy”
We recently published a list of 8 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Interactive Brokers Group, Inc.
Jim Cramer Says “I Want You to Buy Reddit (RDDT) Here”
We recently published a list of 8 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Reddit, Inc.
Jim Cramer Says to Wait “Before You Pull the Trigger” on Chevron Corporation (CVX) Stock
We recently published a list of 8 Stocks on Jim Cramer’s Radar.
Jim Cramer Says “Costco (COST) is Actually on Fire”
We recently published a list of 8 Stocks on Jim Cramer’s Radar.
Jim Cramer Thinks GE Vernova (GEV) is the Only Company “Ready to Profit From New Nuclear Reactors”
We recently published a list of 8 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where GE Vernova Inc.
Goldman Sachs Analyst Reinstates Sell Rating on DBV Technologies Amid VP Treatment Risks
On May 28, Goldman Sachs analyst Rajan Sharma reinstated his sell rating on DBV Technologies S.A. (NASDAQ:DBVT) and set the price target at $7.25.
Barclays Initiates Coverage of Sun Communities (SUI) with Overweight Rating
Sun Communities, Inc. (NYSE:SUI) efforts to streamline operations by selling a marina segment have caught Barclay's attention.
Wells Fargo Downgrades SentinelOne As Management Warns of ARR Slowdown
On May 28, Wells Fargo downgraded SentinelOne, Inc. (NYSE:S) shares to an 'Equal Weight' from an 'Overweight.' It also cut the stock's price target to $18 from $22.
Why These Energy Stocks Are Gaining This Week
America’s nuclear energy sector received a massive boost recently after President Trump signed an executive order aimed at quadrupling the country’s nuclear capacity by 2050...
BofA Lifts Coherent Corporation’s (COHR) Price Target to $92.00, Keeps Buy Rating
Arya based the price target increase on the company's potential for significant growth, updating it after COHR's 2025 Analyst and Investor Day on May 28 on which it detailed its...
Oppenheimer Slashes Price Target on Salesforce (CRM), Maintains an Outperform Rating
On May 29, Oppenheimer analyst Brian Schwartz lowered the firm's price target on Salesforce, Inc.
Bernstein Maintains Underperform Rating on Salesforce (CRM)
The rating update followed the company's fiscal Q1 2026 earnings release, which took place on May 28.
Piper Sandler Reduces Prothena (PRTA) Price Target to $81 from $110 Following AFFIRM-AL Trial Discontinuation
The price target decrease followed the company's May 23 announcement stating that its Phase 3 AFFIRM-AL clinical trial for Birtamimab in AL Amyloidosis patients failed to meet...
Chardan Lowers Prothena (PRTA) Price Target Following AFFIRM-AL Trial Failure
Although the firm is bullish on Prothena Corporation plc (NASDAQ:PRTA), it reduced its price target after the company announced the discontinuation of its Phase 3 AFFIRM-AL clinical...
H.C. Wainwright Maintains Buy Rating on Prothena Corporation (NASDAQ:PRTA), Cuts PT
The price target decrease followed the company's announcement on May 23 that its Phase 3 AFFIRM-AL clinical trial for Birtamimab in AL Amyloidosis patients had failed to meet ...
Susquehanna Maintains Buy Rating on Nvidia (NVDA) After Strong Q1 Report
On May 29, analyst Christopher Rolland from Susquehanna reiterated a Buy rating on NVIDIA Corporation (NASDAQ:NVDA) with a $180.00 price target.
Do You Believe in the Upside Potential of Dollar Tree (DLTR)?
Broyhill Asset Management, an investment advisor, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
What Makes Uber Technologies (UBER) a Lucrative Investment?
Broyhill Asset Management, an investment advisor, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Baxter International (BAX) Traded Higher Despite Tariff Disruptions
Broyhill Asset Management, an investment advisor, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Accelerated Momentum Lifted Philip Morris (PM) in Q1
Broyhill Asset Management, an investment advisor, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Broyhill Asset Management’s Q1 2025 Investor Letter
Broyhill Asset Management, an investment advisor, released its first quarter 2025 investor letter.
Nvidia (NVDA) Experienced a Sell-Off in Q1
Impax Asset Management, an investment management company, released its “Impax Global Environmental Markets Fund” first quarter 2025 investor letter.
Waste Management (WM) Rose on Strong Operational Results
Impax Asset Management, an investment management company, released its “Impax Global Environmental Markets Fund” first quarter 2025 investor letter.
Microsoft (MSFT) Fell Along with Mega-Cap Technology Stocks
Impax Asset Management, an investment management company, released its “Impax Global Environmental Markets Fund” first quarter 2025 investor letter.
Here’s Why Agilent Technologies (A) Traded Lower in Q1
Impax Asset Management, an investment management company, released its “Impax Global Environmental Markets Fund” first quarter 2025 investor letter.
Impax Global Environmental Markets Fund’s Q1 2025 Investor Letter
Impax Asset Management, an investment management company, released its “Impax Global Environmental Markets Fund” first quarter 2025 investor letter.
Generation Investment Management’s Investment Thesis for Agilent Technologies (A)
Generation Investment Management, an investment management firm, released its “Global Equity Strategy” first quarter 2025 investor letter.
Generation Investment Management Global Equity Strategy’s Q1 2025 Investor Letter
Generation Investment Management, an investment management firm, released its “Global Equity Strategy” first quarter 2025 investor letter.
Alphabet (GOOG) Slid Following DeepSeek News
Artisan Partners, an investment management company, released its “Artisan Value Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Canadian Imperial Bank of Commerce (NYSE:CM) Q2 2025 Earnings Call Transcript
Canadian Imperial Bank of Commerce (NYSE:CM) Q2 2025 Earnings Call Transcript May 29, 2025Canadian Imperial Bank of Commerce beats earnings expectations.
B.O.S. Better Online Solutions Ltd. (NASDAQ:BOSC) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BOS conference call.
Burlington Stores, Inc. (NYSE:BURL) Q1 2025 Earnings Call Transcript
Operator: Hello, everyone, and, welcome to Burlington Stores Inc. First Quarter 2025 Earnings Call. Please note that this call is being recorded.
Here’s Why Merck & Co. (MRK) Traded Lower in Q1
Artisan Partners, an investment management company, released its “Artisan Value Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center
